ANA NLP Poster

October 17, 2016 Kerry Rowe

ana-2016-poster-final

Post navigation

WEBCAST LINK: H.C. Wainwright BIOCONNECT Virtual Conference
Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson’s and Alzheimer’s
Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial
Alterity Therapeutics to Participate in Two Upcoming Investor Conferences

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

ANA NLP Poster

Related Posts

Prana Doses First Patient in PBT2 Alzheimer’s Extension Study

Prana to Present at Cowen & Company Health Care Conference on March 4th in Boston, MA

Alterity Therapeutics Presents to Finance News Network